Evidence map›Paper›PMID 25609641›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.

Zoe C Hesp, Evan Z Goldstein, Evan A Goldstein, Carlos J Miranda, Brian K Kaspar, Brain K Kaspar, Dana M McTigue

Erratum issuedAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Spinal Cord Injury Remyelination: Pathways to Therapies.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
    Goldstein, Evan A [Corrected to Goldstein, Evan Z] and Kaspar, Brain K [Corrected to Kaspar, Brian K]
5 · Who and what money

Authors and funding

7 authors.

Zoe C HespNeuroscience Graduate Studies Program.
Evan Z Goldstein
Evan A GoldsteinNeuroscience Graduate Studies Program.
Carlos J MirandaNationwide Children's Hospital, Columbus, Ohio 43205.
Brian K Kaspar
Brain K KasparCenter for Brain and Spinal Cord Repair, The Ohio State University, Columbus, Ohio 43210, and Nationwide Children's Hospital, Columbus, Ohio 43205.ORCID http://orcid.org/0000-0003-2394-0196
Dana M McTigueDepartment of Neuroscience, and Center for Brain and Spinal Cord Repair, The Ohio State University, Columbus, Ohio 43210, and dana.mctigue@osumc.edu.

Funding

Ohio State Neuroscience Centr CoreP30NS045758 · NINDS · OHIO STATE UNIVERSITY · PI OBRIETAN, KARL H · 2004 to 2015
$7.7M
Oligodendrocyte Genesis after Spinal Cord InjuryR01NS059776 · NINDS · OHIO STATE UNIVERSITY · PI MCTIGUE, DANA M · 2009 to 2013
$1.7M
NINDS NIH HHS NS059776NINDS NIH HHS P30 NS045758NINDS NIH HHS P30-NS045758NINDS NIH HHS R01 NS059776
6 · The paper itself

Abstract

Adult progenitor cells proliferate in the acutely injured spinal cord and their progeny differentiate into new oligodendrocytes (OLs) that remyelinate spared axons. Whether this endogenous repair continues beyond the first week postinjury (wpi), however, is unknown. Identifying the duration of this response is essential for guiding therapies targeting improved recovery from spinal cord injury (SCI) by enhancing OL survival and/or remyelination. Here, we used two PDGFRα-reporter mouse lines and rats injected with a GFP-retrovirus to assess progenitor fate through 80 d after injury. Surprisingly, new OLs were generated as late as 3 months after injury and their processes ensheathed axons near and distal to the lesion, colocalized with MBP, and abutted Caspr+ profiles, suggesting newly formed myelin. Semithin sections confirmed stereotypical thin OL remyelination and few bare axons at 10 wpi, indicating that demyelination is relatively rare. Astrocytes in chronic tissue expressed the pro-OL differentiation and survival factors CNTF and FGF-2. In addition, pSTAT3+ NG2 cells were present through at least 5 wpi, revealing active signaling of the Jak/STAT pathway in these cells. The progenitor cell fate genes Sox11, Hes5, Id2, Id4, BMP2, and BMP4 were dynamically regulated for at least 4 wpi. Collectively, these data verify that the chronically injured spinal cord is highly dynamic. Endogenous repair, including oligodendrogenesis and remyelination, continues for several months after SCI, potentially in response to growth factors and/or transcription factor changes. Identifying and understanding spontaneous repair processes such as these is important so that beneficial plasticity is not inadvertently interrupted and effort is not exerted to needlessly duplicate ongoing spontaneous repair.

Indexed as

AnimalsCell DifferentiationDemyelinating DiseasesFemaleMaleMiceNerve RegenerationOligodendrogliaRatsRats, Sprague-DawleyRecovery of FunctionSpinal Cord Injuriesdemyelinationglial scargrowth factorNG2 cellstem celltransplant

Identifiers

PMID25609641
PMCPMC4300327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.